UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]	Research and development services	Research and development services
Revenues	$ 2,832	$ 489
Cost of revenues	2,622	477
Gross profit	210	12
Operating expenses
Research and development	7,670	12,230
Selling, general and administrative	6,181	6,081
Exit and termination (benefits) costs	(414)	1,423
Total operating expenses	13,437	19,734
Loss from operations	(13,227)	(19,722)
Interest income	1,490	2,468
Net loss	$ (11,737)	$ (17,254)
Net loss per share, basic (in USD per share)	$ (0.07)	$ (0.10)
Net loss per share, diluted (in USD per share)	$ (0.07)	$ (0.10)
Weighted-average shares outstanding, basic (in shares)	177,668,678	174,344,218
Weighted-average shares outstanding, diluted (in shares)	177,668,678	174,344,218
Research and development services
Cost of revenues	$ 2,622	$ 477